Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine

Yifeng Qin,Kaihang Tu,Qingyuan Teng,Delan Feng,Ye Zhao,Guozhong Zhang,Yifeng QinKaihang TuQingyuan TengDelan FengYe ZhaoGuozhong ZhangaKey Laboratory of Animal Epidemiology of the Ministry of Agriculture,College of Veterinary Medicine,China Agricultural University,Beijing 100193,People's Republic of China

DOI: https://doi.org/10.1128/jvi.00667-21

IF: 6.549

2021-06-10

Journal of Virology

Abstract:Cellular immune responses play a key role in the control of viral infection. The nucleocapsid (N) protein of infectious bronchitis virus (IBV) is a major immunogenic protein that can induce protective immunity. To screen for potential T-cell epitopes on IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. Four T-cell epitope peptides were identified by IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays; among them, three peptides (N 211–230 , N 271–290 , and N 381–400 ) were CTL epitopes, and one peptide (N 261–280 ) was a dual-specific T-cell epitope, which can be recognized by both CD8 + and CD4 + T cells. Multi-epitope gene transcription cassettes comprising four neutralizing epitope domains and four T-cell epitope peptides were synthesized and inserted into the genome of Newcastle disease virus strain La Sota between the P and M genes. Recombinant IBV multi-epitope vaccine candidate rLa Sota/SBNT was generated via reverse genetics, and its immune protection efficacy was evaluated in specific-pathogen-free chickens. Our results show that rLa Sota/SBNT induced IBV-specific neutralizing antibody and T-cell responses and provided significant protection against homologous and heterologous IBV challenge. Thus, the T-cell epitope peptides identified in this study could be good candidates for IBV vaccine development, and recombinant Newcastle disease virus expressing IBV multi-epitope genes represents a safe and effective vaccine candidate for controlling infectious bronchitis. IMPORTANCE T-cell-mediated immune responses are critical for the elimination of IBV-infected cells. To screen conserved T-cell epitopes in the IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. By combining IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays, we identified three CTL epitopes and one dual-specific T-cell epitope. The value of T-cell epitope peptides identified in the N protein was further verified by the design of an IBV multi-epitope vaccine. Results show that IBV multi-epitope vaccine candidate rLa Sota/SBNT provided cross protection against challenges with a QX-like or a TW-like IBV strain. So T-cell-mediated immune responses play an important role in the control of viral infection and conserved T-cell epitopes serve as promising candidates for use in multi-epitope vaccine construction. Our results provide a new perspective for the development of a safer and more effective IBV vaccine.

virology